New
Image

04.08.2025
68% of people without diabetes or prediabetes have never considered th...
In partnership with Tesco, we surveyed 2,000 people to get an insight into people’s understanding and awa...
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more